[Results of treatment with ethambutol and capreomycin in chronic pulmonary tuberculosis].
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D004361:Drug Tolerance; D004977:Ethambutol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*; D014725:Vestibular Nerve / Q000187:drug effects; D014786:Vision Disorders / Q000139:chemically induced
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D004977:Ethambutol
Wyniki leczenia przewlekłej gruźlicy płuc etambutolem i kapreomycyna.